189 related articles for article (PubMed ID: 21610533)
1. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate-associated femur fractures have high complication rates with operative fixation.
Prasarn ML; Ahn J; Helfet DL; Lane JM; Lorich DG
Clin Orthop Relat Res; 2012 Aug; 470(8):2295-301. PubMed ID: 22669553
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics, densitometric parameters and outcomes of patients with atypical femoral fractures related to bisphosphonate treatment for osteoporosis.
Wong CH; Kan AKC; Tsoi KH; Chan SSY; Jiang NS; Loong CHN; Fong CHY; Wong JSH; Shea GKH; Cheung CL; Lee CH; Tan KCB; Woo YC; Lui DTW
Endocrine; 2024 Apr; 84(1):223-235. PubMed ID: 37985574
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates and atypical femoral fractures: Is the location of the fracture associated with the time of consolidation?
Llano L; Barla J; Taype D; Garcia Barreiro G; Sancineto C; Carabelli G
Injury; 2023 Nov; 54 Suppl 6():110730. PubMed ID: 38143116
[TBL] [Abstract][Full Text] [Related]
5. Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance.
Lloyd AA; Gludovatz B; Riedel C; Luengo EA; Saiyed R; Marty E; Lorich DG; Lane JM; Ritchie RO; Busse B; Donnelly E
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):8722-8727. PubMed ID: 28760963
[TBL] [Abstract][Full Text] [Related]
6. Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.
Qiu S; Dhaliwal R; Divine G; Warner E; Rao SD
J Bone Miner Res; 2024 May; 39(4):417-424. PubMed ID: 38477744
[TBL] [Abstract][Full Text] [Related]
7. A Case Report of Oral Bisphosphonate Treatment for Osteoporosis Leading to Atypical Femoral Fracture and Pathologic Mandibular Fracture.
Fernandes TL; Viezzer Fernandes B; Jitumori C; Franco GCN
Am J Case Rep; 2023 Oct; 24():e941144. PubMed ID: 37867315
[TBL] [Abstract][Full Text] [Related]
8. Preventive bilateral femoral nailing in atypical femoral fracture non responder to anabolic therapy: case report and mini-review.
Neri E; Gabriele L; Bottai V; Andreani L; Bonicoli E; Scaglione M
Acta Biomed; 2022 Jan; 92(S1):e2021130. PubMed ID: 35049529
[TBL] [Abstract][Full Text] [Related]
9. Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases.
Fitzpatrick D; Seebah S; Lannon R; Mc Carroll K
Osteoporos Int; 2023 Oct; 34(10):1807-1808. PubMed ID: 37526671
[No Abstract] [Full Text] [Related]
10. Obliteration of the medullary canal in an atypical bisphosphonate-related femoral fracture.
Cawley DT; Barrett HL; Harrington P
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25568263
[TBL] [Abstract][Full Text] [Related]
11. [Atypical femoral fractures due to the use of bisphosphonates. Experience of two institutions].
Villegas RI; Melo-Durán S; Cevallos A; Barros-Prieto EA
Acta Ortop Mex; 2023; 37(5):270-275. PubMed ID: 38382451
[TBL] [Abstract][Full Text] [Related]
12. Atypical femur fracture in a male without history of bisphosphonate use: a case report.
Al-Ajlouni YA; Lee JL; Lee JL; Samuels B
J Med Case Rep; 2024 Jan; 18(1):2. PubMed ID: 38172929
[TBL] [Abstract][Full Text] [Related]
13. Identifying Complete Atypical Femur Fractures in Adults with Bisphosphonate Exposure.
Lo JC; Grimsrud CD
Endocr Pract; 2024 Mar; 30(3):278-281. PubMed ID: 38110088
[No Abstract] [Full Text] [Related]
14. Delayed healing of lower limb fractures with bisphosphonate therapy.
Yue B; Ng A; Tang H; Joseph S; Richardson M
Ann R Coll Surg Engl; 2015 Jul; 97(5):333-8. PubMed ID: 26264082
[TBL] [Abstract][Full Text] [Related]
15. Determinants of Oral Bisphosphonate Use Beyond 5 Years.
Izano MA; Lo JC; Ettinger B; Ott SM; Li BH; Niu F; Hui RL; Neugebauer R; Adams AL
J Manag Care Spec Pharm; 2020 Feb; 26(2):197-202. PubMed ID: 32011964
[TBL] [Abstract][Full Text] [Related]
16. No Increased Risk of Nonunion with Bisphosphonate Use in a Medicare Claims Cohort Following Operatively Treated Long-Bone Fractures.
Thorne TJ; Steffenson L; O'Neill DC; Marchand LS; Martin BI; Haller JM
J Bone Joint Surg Am; 2023 Apr; 105(7):549-555. PubMed ID: 36753557
[TBL] [Abstract][Full Text] [Related]
17. Antiresorptive Drugs and the Risk of Femoral Shaft Fracture in Men and Women With Osteoporosis: A Cohort Study Using the National Database of Health Insurance Claims of Japan.
Imai T; Hosoi T; Hagino H; Yamamoto T; Kuroda T; Watanabe H; Tanaka S
J Epidemiol; 2023 Dec; 33(12):633-639. PubMed ID: 36567127
[TBL] [Abstract][Full Text] [Related]
18. Position Statement: Atypical Femoral Fracture from the Korean Society for Bone and Mineral Research in 2023.
Nho JH; Jang BW; Lee DW; Kim JH; Lim TK; Cha SM; Seo DK; Park YG; Kang DG; Lee YK; Ha YC
J Bone Metab; 2023 Aug; 30(3):209-217. PubMed ID: 37718899
[TBL] [Abstract][Full Text] [Related]
19. Myocardial infarction risk among patients with fractures receiving bisphosphonates.
Pittman CB; Davis LA; Zeringue AL; Caplan L; Wehmeier KR; Scherrer JF; Xian H; Cunningham FE; McDonald JR; Arnold A; Eisen SA
Mayo Clin Proc; 2014 Jan; 89(1):43-51. PubMed ID: 24388021
[TBL] [Abstract][Full Text] [Related]
20. Intradepartmental orthopaedic fragility fracture liaison improves osteoporosis follow-up and treatment.
Galasso AC; Herzog LN; Sekar M; Hartsock LA; Reid KR
Injury; 2023 Oct; 54(10):110985. PubMed ID: 37599192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
